The effectiveness of switching from tiotropium/indacaterol to glycopyrronium/indacaterol combination in patients with COPD.
Not Applicable
- Conditions
- Chronic obstructive pulmonary disease (COPD)
- Registration Number
- JPRN-UMIN000017301
- Lead Sponsor
- Department of Respiratory Medicine, Shizuoka General Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
-Patients with a history of asthma. -Patients who are already treated with ICS or oral corticosteroid regularly. -Patients who have experienced a COPD exacerbation within the previous 8 weeks. -Patients with uncontrolled cardiac diseases.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in FEV1 between week 0 and week 8
- Secondary Outcome Measures
Name Time Method Change in FVC between week 0 and week 8 Change in FEV1/FVC between week 0 and week 8 Change in FOT parameters between week 0 and week 8 Change in CAT between week 0 and week 8 Change in mMRC between week 0 and week 8